Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Flibanserin

Copy Product Info
🥰Excellent
Catalog No. T4297Cas No. 167933-07-5
Alias Girosa, BIMT-17BS, BIMT-17

Flibanserin (Girosa) is a serotonergic antidepressant used to treat hypoactive sexual desire disorder. Flibanserin has been associated with a low rate of minor serum aminotransferase elevations during treatment but has not been linked to instances of clinically apparent acute liver injury.

Flibanserin

Flibanserin

Copy Product Info
🥰Excellent
Purity: 99.93%
Catalog No. T4297Alias Girosa, BIMT-17BS, BIMT-17Cas No. 167933-07-5
Flibanserin (Girosa) is a serotonergic antidepressant used to treat hypoactive sexual desire disorder. Flibanserin has been associated with a low rate of minor serum aminotransferase elevations during treatment but has not been linked to instances of clinically apparent acute liver injury.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$34In StockIn Stock
10 mg$59In StockIn Stock
25 mg$109In StockIn Stock
50 mg$197In StockIn Stock
100 mg$255In StockIn Stock
200 mg$378In StockIn Stock
1 mL x 10 mM (in DMSO)$39In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.93%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Flibanserin AI Summary
Flibanserin exhibits a multifaceted bioactivity profile, notably including strong interactions with serotonin-related receptors and antiviral properties. It shows a high binding affinity to the human 5-HT1A receptor with a Ki of 11.75 nM and functions as an agonist with an EC50 of 630.96 nM and an Emax of 72.0% relative to 5-hydroxytryptamine. In vivo, it demonstrates antidepressant-like activity in rats, with an ED50 greater than 320 mg/kg in a forced swimming test and inducing forepaw treading and flat body posture at ED50 values greater than 40 mg/kg and 20 mg/kg, respectively. In the context of antiviral activity, Flibanserin inhibits SARS-CoV-2 cytotoxicity in Caco-2 and VERO-6 cells at 10 µM, with a notable inhibition of 56.47% cytotoxicity in Caco-2 cells after 48 hours. It also shows activity against the SARS-CoV-2 3CL-Pro protease at 20 µM via FRET assay, although the inhibition percentages are relatively modest (16.04% and 13.86%). The compound's effect on the USA-WA1/2020 strain of SARS-CoV-2, with a hit score of 0.2785 in HRCE cells, underscores its potential as an antiviral agent. Furthermore, Flibanserin demonstrates inhibitory activity against human HDAC6 with stronger effects observed using commercial peptide substrates (18.44% inhibition). It also binds to various other receptors, including DRD1, DRD3, OPRM1, ADRA2A, showing its potential involvement in multiple signaling pathways. Its complex pharmacological profile includes activities as both an agonist and antagonist across different receptors and enzymes. Overall, Flibanserin is a compound of significant interest for its diverse biological activities and therapeutic potential..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Flibanserin (Girosa) is a serotonergic antidepressant used to treat hypoactive sexual desire disorder. Flibanserin has been associated with a low rate of minor serum aminotransferase elevations during treatment but has not been linked to instances of clinically apparent acute liver injury.
Targets&IC50
5-HT1A:1 nM(Ki), D4 receptor:4-24 nM(Ki), 5-HT2A:49 nM(Ki)
SynonymsGirosa, BIMT-17BS, BIMT-17
Chemical Properties
Molecular Weight390.4
FormulaC20H21F3N4O
Cas No.167933-07-5
SmilesC(CN1CCN(CC1)C2=CC(C(F)(F)F)=CC=C2)N3C=4C(NC3=O)=CC=CC4
Relative Density.1.292 g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 50 mg/mL (128.07 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.12 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5615 mL12.8074 mL25.6148 mL128.0738 mL
5 mM0.5123 mL2.5615 mL5.1230 mL25.6148 mL
10 mM0.2561 mL1.2807 mL2.5615 mL12.8074 mL
20 mM0.1281 mL0.6404 mL1.2807 mL6.4037 mL
50 mM0.0512 mL0.2561 mL0.5123 mL2.5615 mL
100 mM0.0256 mL0.1281 mL0.2561 mL1.2807 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Flibanserin | purchase Flibanserin | Flibanserin cost | order Flibanserin | Flibanserin chemical structure | Flibanserin formula | Flibanserin molecular weight